Aviance Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-830	Closed	-$386K	–	346
2024 Q3	$386K	Buy	830 +149	+22%	+$69.3K	0.05%	244
2024 Q2	$319K	Buy	681 +114	+20%	+$53.4K	0.05%	256
2024 Q1	$237K	Hold	567	–	–	0.04%	283
2023 Q4	$231K	Buy	+567	New	+$231K	0.05%	225